Evidence map›Paper›PMID 39505329›Full record

Trial reportNan fang yi ke da xue xue bao = Journal of Southern Medical University2024

[Respiratory complications of propofol, sevoflurane, and dexmedetomidine anesthesia for fiberoptic bronchoscopy in children aged 1 month to 3 years: a randomized trial].

Shafa Amir, Montasery Mohammad, Shahhosseini Sedighe, Keivanfar Majid, Maghami Mehr Asieh, Ebrahim Babaei Mahtab, Jafari Mohammad

Abstract readRandomized Controlled TrialEnglish Abstract
In one paragraph

Trial report in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shafa AmirDepartment of Anesthesiology.
Montasery MohammadAnesthesiology and Critical Care Research Center.
Shahhosseini SedigheDepartment of Anesthesiology.
Keivanfar MajidDepartment of Pediatrics, Isfahan University of Medical Sciences, Isfahan, Iran.
Maghami Mehr AsiehDepartment of Statistics, Yazd University, Yazd, Iran.
Ebrahim Babaei MahtabDepartments of Obstetrics and Gynecology, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Jafari MohammadDepartment of Anesthesiology.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the effect of propofol, sevoflurane, and dexmedetomidine on respiratory complications in children undergoing fiberoptic bronchoscopy (FOB).

methodsThis double-blind randomized clinical trial was conducted among 120 children aged 1 month to 3 years undergoing FOB. The patients were randomized into 3 groups (

resultsThe patients' heart rate during bronchoscopy was significantly lower and the mean arterial blood pressure significantly higher in dexmedetomidine group than in sevoflurane and propofol groups (

conclusionSevoflurane and propofol are safe and suitable for anesthesia induction in children below 3 years of age undergoing diagnostic FOB and can achieve better sedative effect and lower the incidences of cough and respiratory complications as compared with dexmedetomidine.

Indexed as

BronchoscopyDexmedetomidinePropofolSevofluraneAnesthetics, InhalationChild, PreschoolCoughDouble-Blind MethodFemaleHumansHypnotics and SedativesInfantMaleMethyl EthersAnesthetics, InhalationDexmedetomidineHypnotics and SedativesMethyl EthersPropofolSevofluranechildrendexmedetomidinefiberoptic bronchoscopypropofolsevoflurane

Identifiers

PMID39505329
PMCPMC11744078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.